GINA CARROLL: Open Payments
NPI 1265953699 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$85 in 4 payments from 4 companies in 2025. Trend: 2023 $120 · 2024 $17 · 2025 $85
Food & beverage: $85
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Alkermes, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: INGREZZA, CAPLYTA, LYBALVI, REXULTI.
Industry payments across VA — which companies pay providers there.
